Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Clinical genetics · APECED and FOXN1 Deficiency

Genetic Syndromes: When Genes Affect Both Hair and Immunity

At a Glance

APECED usually develops in childhood or adolescence, causing autoimmune attacks, chronic candidiasis, endocrine problems, and often alopecia. FOXN1 deficiency is present from birth, with congenital hair loss, an absent thymus, severe T-cell immunodeficiency, and serious infections.

When hair loss and antibody problems occur together due to a single genetic cause, doctors often look for two specific, rare conditions: APECED and FOXN1 deficiency. While both involve alopecia and a struggling immune system, they are distinct clinical diagnoses.

APECED (APS-1): An Autoimmune Endocrine Syndrome

APECED (Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy) is caused by mutations in the AIRE gene [1].

Normally, the AIRE gene acts like a “school teacher” in the thymus gland, showing developing immune cells a catalog of the body’s own proteins so they learn not to attack them [2]. Without a working AIRE gene, “self-reactive” immune cells escape into the body and begin attacking your own organs [3].

The Signs of APECED

This condition usually appears in childhood or adolescence and is primarily an autoimmune endocrine syndrome. Its classic triad includes:

  • Chronic Mucocutaneous Candidiasis: Persistent, hard-to-treat yeast infections (thrush) of the mouth, skin, and nails [4].
  • Hypoparathyroidism: A failure of the parathyroid glands that leads to low calcium levels [5].
  • Primary Adrenal Insufficiency: When the adrenal glands stop producing vital stress hormones like cortisol [4].

Alopecia is a common “non-triad” feature. It usually presents as Alopecia Areata (patchy loss) but can progress to complete scalp or body hair loss [6]. In APECED, your immune system is actively attacking your endocrine glands and hair follicles; hypogammaglobulinemia is not its defining immune problem.

Testing for APECED

A key marker for APECED is the presence of anti-type-I-interferon autoantibodies (like anti-IFN-omega). These are highly characteristic of the disease in targeted populations [7][8]. (A negative result does not exclude disease, and a positive result should be interpreted clinically). Confirmation is done through AIRE gene sequencing [9].

FOXN1 Deficiency: A Severe T-Cell Immunodeficiency

While APECED is an autoimmune attack that develops over time, FOXN1 deficiency (also known as Nude SCID) is a developmental problem present from the moment of birth [10].

The FOXN1 gene is essential for building the thymus gland (where T-cells mature) and the structures of the skin and hair [11]. When this gene is missing or broken, the body fails to develop a thymus (athymia).

The Signs of FOXN1 Deficiency

  • Congenital Alopecia: Children with FOXN1 deficiency are often born with no hair, including no eyebrows or eyelashes [10].
  • Nail Dystrophy: The nails may be thickened, ridged, or unusually shaped from birth [11].
  • Severe T-Cell Immunodeficiency: The body lacks thymus-derived T-cells. While B and NK cells may be numerically preserved, antibody responses can be severely impaired because T-cell help is absent. This leads to a profound combined immunodeficiency and a high risk of life-threatening viral and fungal infections in infancy [12][13].

Testing for FOXN1 Deficiency

If a baby is born with no hair and a weak immune system, doctors will look for:

  • Abnormal Newborn Screening: Many regions use a “TREC test” at birth that can detect a lack of T-cells [10].
  • T-cell Subset Panel: A blood test to check T-cell counts [13].
  • Genetic Testing: Specifically looking for mutations in the FOXN1 gene [11].

(Treatment note: Cultured thymus tissue implantation is a specialized option for selected patients with congenital athymia. Stem-cell transplantation is not routine for isolated FOXN1-related athymia.)

Comparing the Two Paths

Feature APECED (APS-1) FOXN1 Deficiency
Timing of Onset Childhood or Adolescence [4] At Birth (Congenital) [10]
Primary Immune Problem Autoimmune (Attack on self) [2] T-cell Immunodeficiency [11]
Hallmark Infection Chronic yeast (Candidiasis) [14] Severe viral/opportunistic infections [13]
Hormone Issues Adrenal & Parathyroid failure [5] Not a primary feature
Hair Loss Pattern Often patchy, starts later [6] Complete hair loss from birth [10]
Key Gene AIRE [1] FOXN1 [11]

Genetic Counseling: Because testing can reveal inheritance patterns or yield variants of uncertain significance, a referral to a genetic counselor is highly recommended before predictive testing or testing children.

Common questions in this guide

How are APECED and FOXN1 deficiency different?
APECED is an autoimmune condition caused by AIRE changes that usually appears in childhood or adolescence. FOXN1 deficiency is present from birth because the thymus does not develop normally, causing severe T-cell immune deficiency and congenital hair loss. APECED more often features chronic candidiasis and endocrine gland problems, while FOXN1 deficiency is linked to severe viral and fungal infections in infancy.
What can the timing of hair loss suggest about an immune disorder?
Hair loss from birth, including absent eyebrows or eyelashes, together with nail changes and serious infections can raise concern for FOXN1 deficiency. Hair loss that begins later and occurs in patches is more consistent with the pattern often seen in APECED, especially when chronic thrush or endocrine problems are present. Only clinical evaluation and genetic testing can distinguish these conditions.
How is APECED evaluated?
Evaluation may include testing for anti-type-I-interferon autoantibodies and sequencing of the AIRE gene. Because APECED can cause hypoparathyroidism, clinicians may also check calcium and parathyroid hormone, even if low-calcium symptoms are absent. A negative antibody result does not exclude the condition, and a positive result needs clinical interpretation.
Which tests can identify FOXN1 deficiency?
Evaluation may include a TREC newborn screen, a blood test measuring T-cell subsets, and genetic testing for FOXN1 changes. Together, these tests help assess whether the thymus is absent or underdeveloped and whether the immune problem is related to FOXN1.
Can APECED cause low antibody levels or recurrent infections?
APECED is primarily an autoimmune disorder rather than a classic antibody-deficiency condition. Chronic mucocutaneous candidiasis is a hallmark, while low immunoglobulin levels are not the defining immune problem. If recurrent infections suggest antibody deficiency, clinicians may need to look for another or additional immune disorder.
What treatment options are available for FOXN1 deficiency?
Selected patients with congenital athymia may be considered for cultured thymus tissue implantation at a specialized center. Stem-cell transplantation is not routine for isolated FOXN1-related athymia, and infection prevention and treatment require specialist immunology care.
How is persistent thrush managed when APECED is suspected?
Persistent thrush in APECED is usually treated with antifungal medication as directed by a clinician. Its recurrence can reflect the immune dysfunction associated with anti-type-I-interferon autoantibodies, but infection treatment and antibody testing are separate decisions. Recurrent or hard-to-treat infections warrant evaluation for APECED and other immune conditions.

Get notified when new evidence is published on Alopecia antibody deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

    Ferré EMN, Schmitt MM, Lionakis MS

    Frontiers in pediatrics 2021; (9()):723532 doi:10.3389/fped.2021.723532.

    PMID: 34790633
  2. 2

    Autoimmune regulator and self-tolerance - molecular and clinical aspects.

    Abramson J, Husebye ES

    Immunological reviews 2016; (271(1)):127-40 doi:10.1111/imr.12419.

    PMID: 27088911
  3. 3

    [Induction of central tolerance by the factor Aire: molecular and epigenetic regulation].

    Lopes N, Ferrier P, Irla M

    Medecine sciences : M/S 2015; (31(8-9)):742-7 doi:10.1051/medsci/20153108012.

    PMID: 26340833
  4. 4

    Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.

    Sharifinejad N, Zaki-Dizaji M, Tebyanian S, et al.

    Expert review of clinical immunology 2021; (17(8)):807-817 doi:10.1080/1744666X.2021.1925543.

    PMID: 33957837
  5. 5

    Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.

    Sandru F, Petca RC, Dumitrascu MC, et al.

    Biomedicines 2024; (12(1)) doi:10.3390/biomedicines12010132.

    PMID: 38255237
  6. 6

    Alopecia areata and occurrence of vitiligo and hypothyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

    Englander H, Ferré EMN, Schmitt MM, et al.

    Pediatric dermatology 2023; (40(5)):857-859 doi:10.1111/pde.15380.

    PMID: 37495514
  7. 7

    Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

    Ferre EM, Rose SR, Rosenzweig SD, et al.

    JCI insight 2016; (1(13)).

    PMID: 27588307
  8. 8

    Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies.

    Paldino G, Faienza MF, Cappa M, et al.

    Frontiers in immunology 2023; (14()):1172369 doi:10.3389/fimmu.2023.1172369.

    PMID: 37457714
  9. 9

    Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway.

    Kucuka I, Wolff ASB, Breivik L, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(7)):1927-1939 doi:10.1210/clinem/dgag060.

    PMID: 41678364
  10. 10

    T-Cell Immunodeficiencies With Congenital Alterations of Thymic Development: Genes Implicated and Differential Immunological and Clinical Features.

    Giardino G, Borzacchiello C, De Luca M, et al.

    Frontiers in immunology 2020; (11()):1837 doi:10.3389/fimmu.2020.01837.

    PMID: 32922396
  11. 11

    FOXN1 deficient nude severe combined immunodeficiency.

    Rota IA, Dhalla F

    Orphanet journal of rare diseases 2017; (12(1)):6 doi:10.1186/s13023-016-0557-1.

    PMID: 28077132
  12. 12

    Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment.

    Collins C, Sharpe E, Silber A, et al.

    Journal of clinical immunology 2021; (41(5)):881-895 doi:10.1007/s10875-021-01059-7.

    PMID: 33987750
  13. 13

    FOXN1 Italian founder mutation in Indian family: Implications in prenatal diagnosis.

    Radha Rama Devi A, Panday NN, Naushad SM

    Gene 2017; (627()):222-225 doi:10.1016/j.gene.2017.06.033.

    PMID: 28636882
  14. 14

    Infections in the monogenic autoimmune syndrome APECED.

    Oikonomou V, Break TJ, Gaffen SL, et al.

    Current opinion in immunology 2021; (72()):286-297 doi:10.1016/j.coi.2021.07.011.

    PMID: 34418591

This comparison of APECED and FOXN1 deficiency is for informational purposes only and does not constitute medical advice. A clinical immunologist, geneticist, or other qualified clinician should interpret testing and discuss treatment for your situation.